Thomas B. Casale

Active 1982–2025

Also published as
THOMAS B. CASALE
183
Papers
29,760
Citations
87
h-index
175
i10-index

Citations

Citations per year for Thomas B. Casale1979: 1 citations1983: 1 citations1986: 3 citations1987: 4 citations1988: 9 citations1989: 5 citations1990: 11 citations1991: 10 citations1992: 7 citations1993: 5 citations1994: 8 citations1995: 7 citations1996: 10 citations1997: 18 citations1998: 19 citations1999: 28 citations2000: 15 citations2001: 28 citations2002: 16 citations2003: 37 citations2004: 39 citations2005: 50 citations2006: 58 citations2007: 51 citations2008: 68 citations2009: 53 citations2010: 98 citations2011: 133 citations2012: 172 citations2013: 191 citations2014: 223 citations2015: 229 citations2016: 217 citations2017: 242 citations2018: 209 citations2019: 901 citations2020: 1,004 citations2021: 885 citations2022: 846 citations2023: 659 citations2024: 984 citations2025: 531 citations2026: 8 citations1980–1982: no citations, so these years are not shown1984–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,035 citing papers, 13.9% of this breakdownUnited Kingdom: 1,178 citing papers, 8.1% of this breakdownGermany: 824 citing papers, 5.6% of this breakdownItaly: 799 citing papers, 5.5% of this breakdownChina: 720 citing papers, 4.9% of this breakdownSpain: 587 citing papers, 4% of this breakdownFrance: 554 citing papers, 3.8% of this breakdownCanada: 526 citing papers, 3.6% of this breakdownNetherlands: 476 citing papers, 3.3% of this breakdownAustralia: 414 citing papers, 2.8% of this breakdownSwitzerland: 408 citing papers, 2.8% of this breakdownJapan: 379 citing papers, 2.6% of this breakdown
0%13.9%Other 39.1%

Fields

  • Medicine82.2%
  • Immunology and Microbiology5.6%
  • Biochemistry, Genetics and Molecular Biology5.2%
  • Environmental Science1.2%
  • Health Professions1.2%
  • Agricultural and Biological Sciences1%
  • Other3.6%

Topics

  • Asthma and respiratory diseases20.5%
  • Allergic Rhinitis and Sensitization11.9%
  • Respiratory and Cough-Related Research5.5%
  • Dermatology and Skin Diseases4.1%
  • Food Allergy and Anaphylaxis Research3.8%
  • Urticaria and Related Conditions3.4%
  • Other50.8%

Coauthors

All papers

Open in search
  1. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robyn E. O’Hehir, Ken Ohta, Petr Panzner, Nikolaos G. Papadopoulos, Hae‐Sim Park, Gianni Passalacqua, Ruby Pawankar, David Price, John J. Riva, Yetiani Roldán, Dermot Ryan, Behnam Sadeghirad, Bolesław Samoliński, Peter Schmid‐Grendelmeier, Aziz Sheikh, Alkis Togias, Antonio Valero, Arūnas Valiulis, Erkka Valovirta, Matthew Ventresca, Dana Wallace, Susan Waserman, Magnus Wickman, Wojtek Wiercioch, Juan José Yepes-Núñez, Luo Zhang, Yuan Zhang, Mihaela Zidarn, Torsten Zuberbier, Holger J. Schünemann - Journal of Allergy and Clinical Immunology 2017 cited by 1,997

  2. An expert consensus framework for asthma remission as a treatment goal

    Authors: , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2019 cited by 407

  3. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carrie E. Flanagan, Wytske J. Fokkens, Christine B. Franzese, Matthew Greenhawt, Amarbir S. Gill, Ashleigh A. Halderman, Jens M. Hohlfeld, Cristoforo Incorvaia, Stephanie Joe, Shyam Joshi, Merin Kuruvilla, Jean Kim, Adam M. Klein, Helene J. Krouse, Edward C. Kuan, David M. Lang, Désirée Larenas‐Linnemann, Adrienne M. Laury, Matt Lechner, Stella E. Lee, Victoria S. Lee, Patricia A. Loftus, Sonya Marcus, Haidy Marzouk, José L. Mattos, Edward D. McCoul, Erik Melén, James W. Mims, Joaquim Mullol, Jayakar V. Nayak, John Oppenheimer, Richard R. Orlandi, Katie M. Phillips, Michael P. Platt, Murugappan Ramanathan, Mallory Raymond, Chae‐Seo Rhee, Sietze Reitsma, Matthew W. Ryan, J. Sastre, Rodney J. Schlosser, Theodore A. Schuman, Marcus Shaker, Aziz Sheikh, Kristine A. Smith, Michael Soyka, Masayoshi Takashima, Monica Tang, Pongsakorn Tantilipikorn, Malcolm B. Taw, Jody Tversky, Matthew A. Tyler, Maria C. Veling, Dana Wallace, De Yun Wang, Andrew A. White, Luo Zhang - International Forum of Allergy & Rhinology 2023 cited by 444

  4. Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

    Authors: , , , , , , , , , , - New England Journal of Medicine 2013 cited by 1,076

  5. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2009 cited by 1,926

  6. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wienczyslawa Czarlewski, Gennaro D’Amato, Philippe Devillier, Mark S. Dykewicz, Motohiro Ebisawa, Jean-Louis Fauquert, Wytske J. Fokkens, João Fonseca, Jean-François Fontaine, Bilun Gemicioğlu, Roy Gerth van Wijk, Tari Haahtela, Susanne Halken, Despo Ierodiakonou, Tomohisa Iinuma, Juan Carlos Ivancevich, Marek Jutel, Ігор Петрович Кайдашев, Musa Khaitov, Ömer Kalaycı, Jörg Kleine‐Tebbe, Marek L. Kowalski, Piotr Kuna, Violeta Kvedarienė, Stefania La Grutta, Désirée Larenas‐Linnemann, Susanne Lau, Daniel Laune, Lan Le, P. Lieberman, Karin C. Lødrup Carlsen, Olga Lourenço, Gert Mariën, Pedro Martins, Erik Melén, Enrica Menditto, Hugo Neffen, Grégoire Mercier, Ralph Mosgues, Joaquim Mullol, Antonella Muraro, Leyla S. Namazova-Baranova, Ettore Novellino, Robyn E. O’Hehir, Yoshitaka Okamoto, Ken Ohta, Hae‐Sim Park, Petr Panzner, Giovanni Passalacqua, N. Pham‐Thi, David Price, Graham Roberts, Nicolás Roche, C. Rolland, Nelson Rosario, Dermot Ryan, Bolesław Samoliński, Mario Sánchez‐Borges, Glenis K. Scadding, Mohamed H. Shamji, Aziz Sheikh, Ana Todo‐Bom, Sanna Toppila‐Salmi, Ioana Tsiligianni, Marylin Valentín-Rostán, Arūnas Valiulis, Erkka Valovirta, Maria Teresa Ventura, Samantha Walker, Susan Waserman and 2 more - Journal of Allergy and Clinical Immunology 2019 cited by 571

  7. Allergic Endotypes and Phenotypes of Asthma

    Authors: , , , - The Journal of Allergy and Clinical Immunology In Practice 2020 cited by 306

  8. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2024 cited by 143

  9. Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control

    Authors: , , , , , , , , , - Journal of Allergy and Clinical Immunology 2014 cited by 412

  10. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jürgen Schwarze, Pablo Alonso‐Coello, Óscar Palomares, Marek Jutel - Allergy 2020 cited by 396

  11. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

    Authors: , , , , , , , , , - Journal of Allergy and Clinical Immunology 2010 cited by 1,835

  12. EAACI Biologicals Guidelines—Recommendations for severe asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marek Jutel - Allergy 2020 cited by 273

  13. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

    Authors: , , , , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2022 cited by 89

  14. Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

    Authors: , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2018 cited by 276

  15. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome

    Authors: , , , , , , , , , - Journal of Allergy and Clinical Immunology 2011 cited by 1,152

  16. TH17 cells and corticosteroid insensitivity in severe asthma

    Authors: , , , - Journal of Allergy and Clinical Immunology 2021 cited by 117

  17. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis

    Authors: , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 142

  18. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas B. Casale, Gary Berman, John J. Condemi, Leon S. Greos, Shaila U Gogate, Ellen Sher, Jason Friesen, Eric Schenkel, David I. Bernstein, Jonathan Corren, Krishna M. Sundar, Mark H. Gotfried, Anthony Montanaro, William R. Lumry, Niran J. Amar, Michael Kaplan, Bruce M. Prenner, Thomas Murphy, James Good, Sean Parker, Tim Harrison, Ian Pavord, Christopher E. Brightling, Ratko Djukanović, Douglas McQuaid, Michael Denenberg, Neil Ettinger, Vivek Iyer - The Lancet Respiratory Medicine 2020 cited by 224

  19. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Authors: , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 95

  20. Hot topics in allergen immunotherapy, 2023: Current status and future perspective

    Authors: , , , , , , , , , , , - Allergy 2023 cited by 61

  21. Development and validation of combined symptom‐medication scores for allergic rhinitis*

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wystke J. Fokkens, Bilun Gemicioğlu, Tari Haahtela, Maddalena Illario, Juan Carlos Ivancevich, Violeta Kvedarienė, Piotr Kuna, Désirée Larenas‐Linnemann, Μichael Μakris, Eve Mathieu‐Dupas, Erik Melén, Mário Morais‐Almeida, Ralph Mösges, Joaquim Mullol, Kari C. Nadeau, N. Pham‐Thi, Robyn E. O’Hehir, Frederico S. Regateiro, Sietze Reitsma, Bolesław Samoliński, Aziz Sheikh, Cristiana Stellato, Ana Todo‐Bom, Peter Valentin Tomazic, Sanna Toppila‐Salmi, Antonio Valero, Arūnas Valiulis, Maria Teresa Ventura, Dana Wallace, Susan Waserman, Arzu Yorgancıoğlu, Govert de Vries, M. van Eerd, Petra Zieglmayer, Torsten Zuberbier, Oliver Pfaar, João Fonseca, Jean Bousquet - Allergy 2021 cited by 73

  22. The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fernando Holguín, Daniel J. Jackson, John James, Nizar N. Jarjour, Nicholas J. Kenyon, Sumita Khatri, John P. Kirwan, Monica Kraft, Jerry A. Krishnan, Andrew H. Liu, Mark C. Liu, Miriam Marquis, Fernando D. Martínez, Jacob T. Mey, Wendy C. Moore, James N. Moy, Victor E. Ortega, David B. Peden, Emily Pennington, Michael C. Peters, Kristie Ross, Maria Sanchez, Lewis J. Smith, Ronald L. Sorkness, Michael E. Wechsler, Sally E. Wenzel, Steven R. White, Joe Zein, Amir A. Zeki, Patricia Noël, Dean Billheimer, Eugene R. Bleecker, Emily Branch, Michelle Conway, Cori Daines, Isaac Deaton, Alexandria Evans, Paige Field, David Francisco, Annette T. Hastie, Bob Hmieleski, Jeffrey Krings, Yanqin Liu, Janell L. Merchen, Deborah A. Meyers, Nirushan Narendran, Stephen P. Peters, Anna Pippins, Matthew A. Rank, Ronald Schunk, Raymond Skeps, Benjamín Wright, Tina Banzon, Lisa M. Bartnikas, Sachin N. Baxi, Vishwanath Betapudi, Isabelle Brick, Conor Brockway, Thomas B. Casale, Kathleen Castillo-Ruano, M Cinelli, Elena Crestani, Amparito Cunningham, Megan Day‐Lewis, Natalie M. Diaz-Cabrera, Angela DiMango, Brittany Esty, Eva Fandozzi, Jesse Fernandez, Elizabeth M. Fitzpatrick and 212 more - Journal of Allergy and Clinical Immunology 2021 cited by 61

  23. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jürgen Schwarze, Carlos Canelo‐Aybar, Óscar Palomares, Marek Jutel - Allergy 2020 cited by 139

  24. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air® real‐world data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Juan Carlos Ivancevich, Zhanat Ispayeva, Marek Jutel, Piotr Kuna, Ігор Петрович Кайдашев, Helga Kraxner, Désirée Larenas‐Linnemann, Daniel Laune, Brian J. Lipworth, Renaud Louis, Μichael Μakris, Riccardo Monti, Mário Morais‐Almeida, Ralph Mösges, Joaquim Mullol, Mikaëla Odemyr, Yoshitaka Okamoto, Nikolaos G. Papadopoulos, Vincenzo Patella, N. Pham‐Thi, Frederico S. Regateiro, Sietze Reitsma, Philip W. Rouadi, Bolesław Samoliński, Milan Sova, Ana Todo‐Bom, Luís Taborda‐Barata, Peter Valentin Tomazic, Sanna Toppila‐Salmi, J. Sastre, Ioanna Tsiligianni, Arūnas Valiulis, Olivier Vandenplas, Dana Wallace, Susan Waserman, Arzu Yorgancıoğlu, Mihaela Zidarn, Torsten Zuberbier, João Fonseca, Jean Bousquet - Allergy 2022 cited by 61